[Childhood acute megakaryoblastic leukemia]

Qi Lei1, Ying Liu, Suo-Qin Tang

  • 1Department of Pediatrics, General Hospital of PLA, Beijing 100853, China.

Insights

Childhood acute megakaryoblastic leukemia is rare and challenging to diagnose. Advanced techniques like flow cytometry and immunohistochemistry aid in its detection and prognosis assessment.

Area of Science:

  • Pediatric Hematology Oncology
  • Cellular Biology

Background:

  • Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia.
  • Childhood AMKL presents unique diagnostic challenges due to its rarity and potential for misdiagnosis.

Observation:

  • Clinical presentation included fever, hemorrhage, hepatosplenomegaly, and lymphadenopathy.
  • Bone marrow examination revealed over 30% megakaryoblasts.
  • Flow cytometry showed dual CD41 and CD61 expression; immunohistochemistry identified CD42b(+) cells.

Findings:

  • The case was diagnosed as acute megakaryoblastic leukemia based on morphological, immunophenotypic, and histopathological findings.
  • Dual CD41/CD61 expression and CD42b(+) cell infiltration are key diagnostic markers.

Implications:

  • Accurate diagnosis of childhood AMKL is crucial for appropriate treatment and management.
  • Flow cytometry and immunohistochemistry are vital tools for confirming AMKL and predicting patient outcomes.
  • Early detection and accurate subtyping of leukemia improve prognostic evaluation in pediatric patients.